Literature DB >> 9406947

mRNA for the m4 muscarinic receptor subtype is expressed in adult rat brain cholinergic neurons.

K Sugaya1, C Clamp, D Bryan, M McKinney.   

Abstract

A number of pharmacological, anatomical, and immunological studies have previously addressed the subtype identity of the hippocampal muscarinic pre-synaptic autoreceptor. A preponderance of findings indicate that it is of the M2 pharmacological type. Both the m2 and m4 molecular subtypes exhibit M2 pharmacology and there are few drugs that differentiate between these receptors. Pharmacological attempts at defining the hippocampal autoreceptor have yielded conflicting results. The basal forebrain is relatively enriched in m2 muscarinic receptor mRNA and protein, and lesions that denervate the hippocampus of its basal forebrain cholinergic input have shown a decrement in m2, but not m4, receptor protein in the hippocampus. Thus, the anatomical data obtained to date tend to support the view that the m2 subtype is expressed as the hippocampal autoreceptor. We have combined in situ hybridization histochemistry (ISHH) with immunocytochemistry to choline acetyltransferase to examine whether mRNA for the m4 subtype of muscarinic receptor is expressed in central cholinergic neurons. The m4 muscarinic mRNA was found at moderate levels in all subdivisions of the cholinergic basal forebrain, including the medial septum/diagonal band complex (MS/DB). The m4 mRNA was also found in striatal cholinergic interneurons, in the cholinergic reticular core of the upper brainstem, and in brainstem cholinergic motor neurons. Muscarinic m4 receptor mRNA was also found in many non-cholinergic cells in the brain. For example, the hippocampal pyramidal neurons, dentate gyrus granule cells, and entorhinal cortical pyramidal neurons express relatively high levels of m4 mRNA, while in the brainstem the dorsal raphe and pontine reticular nuclei express relatively high levels of this mRNA. The finding of m4 mRNA in the MS/DB cholinergic neurons suggests that this receptor protein might be expressed as an autoreceptor in hippocampal cholinergic terminals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406947     DOI: 10.1016/s0169-328x(97)00199-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

1.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

2.  The role of N-, Q- and R-type Ca2+ channels in feedback inhibition of ACh release from rat basal forebrain neurones.

Authors:  T G Allen
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

3.  Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Authors:  Anders Fink-Jensen; Lene S Schmidt; Ditte Dencker; Christina Schülein; Jürgen Wess; Gitta Wörtwein; David P D Woldbye
Journal:  Eur J Pharmacol       Date:  2011-01-24       Impact factor: 4.432

Review 4.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

5.  Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.

Authors:  Kristi A Kohlmeier; Masaru Ishibashi; Jürgen Wess; Martha E Bickford; Christopher S Leonard
Journal:  J Neurophysiol       Date:  2012-09-05       Impact factor: 2.714

6.  Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.

Authors:  Lene S Schmidt; Morgane Thomsen; Pia Weikop; Ditte Dencker; Jürgen Wess; David P D Woldbye; Gitta Wortwein; Anders Fink-Jensen
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

7.  Cortical neuronal activity does not regulate sleep homeostasis.

Authors:  M-H Qiu; M C Chen; J Lu
Journal:  Neuroscience       Date:  2015-04-09       Impact factor: 3.590

8.  Coexpression of glutamate vesicular transporter (VGLUT1) and choline acetyltransferase (ChAT) proteins in fetal rat hippocampal neurons in culture.

Authors:  Neelima Bhargava; Mainak Das; Darin Edwards; Maria Stancescu; Jung-Fong Kang; James J Hickman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-15       Impact factor: 2.416

9.  Optimized Administration of the M4 PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2+/- Mice.

Authors:  Jakub Cikowski; Calista Holt; Bright Arthur; Mackenzie Smith; Sonia Gonzalez; Craig W Lindsley; Colleen M Niswender; Rocco G Gogliotti
Journal:  ACS Chem Neurosci       Date:  2022-06-07       Impact factor: 5.780

10.  Interactions between the neuromodulatory systems and the amygdala: exploratory survey using the Allen Mouse Brain Atlas.

Authors:  Andrew Zaldivar; Jeffrey L Krichmar
Journal:  Brain Struct Funct       Date:  2012-11-13       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.